Aurora kinase A as a rational target for therapy in glioblastoma: Laboratory investigation

Journal of Neurosurgery: Pediatrics

Volumn 6, Issue 1, 2010, Pages 98-105

  Barton, Valerie N ^a,c   Foreman, Nicholas K ^a,c   Donson, Andrew M ^a,c   Birks, Diane K ^b,c   Handler, Michael H ^b,c   Vibhakar, Rajeev ^a,c  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

AURKA; Glioblastoma; H2AX; Microarray

Indexed keywords

AURORA A KINASE; AURORA KINASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TARGETING; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MITOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCHOOL CHILD; TUMOR GENE;

ANILIDES; BRAIN NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PYRIMIDINES; RADIATION TOLERANCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77954370343     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2010.3.PEDS10120     Document Type: Article

References (29)

1. Addo-Yobo SO, Straessle J, Anwar A, Donson AM, Kleinschmidt- Demasters BK, Foreman NK: Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma. J Neuropathol Exp Neurol 65:769-775, 2006
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al: Gene ontology: tool for the unification of biology. Nat Genet 25:25-29, 2000
3. Baba Y, Nosho K, Shima K, Irahara N, Kure S, Toyoda S, et al: Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia 11:418-425, 2009
4. Barton VN, Donson AM, Kleinschmidt-Demasters BK, Birks DK, Handler MH, Foreman NK: Unique molecular characteristics of pediatric myxopapillary ependymoma. Brain Pathol [epub ahead of print], 2009
5. Central Brain Tumor Registry of the United States: CBTRUS Statistical Report: Primary Brain Tumors in the United States, 2000-2004. Central Brain Tumor Registry of the United States, 2008
6. Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55, 1984
7. Dar AA, Goff LW, Majid S, Berlin J, El-Rifai W: Aurora kinase inhibitors - rising stars in cancer therapeutics? Mol Cancer Ther 9:268-278, 2010
8. DeAngelis LM: Brain tumors. N Engl J Med 344:114-123, 2001
9. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3, 2003
10. Donson AM, Banerjee A, Gamboni-Robertson F, Fleitz JM, Foreman NK: Protein kinase C zeta isoform is critical for proliferation in human glioblastoma cell lines. J Neurooncol 47:109-115, 2000
11. Donson AM, Birks DK, Barton VN, Wei Q, Kleinschmidt-Demasters BK, Handler MH, et al: Immune gene and cell enrichment is associated with a good prognosis in ependymoma. J Immunol 183:7428-7440, 2009
12. Donson AM, Weil MD, Foreman NK: Tamoxifen radiosensitization in human glioblastoma cell lines. J Neurosurg 90: 533-536, 1999 (Pubitemid 29104603)
13. Giet R, Petretti C, Prigent C: Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol 15:241-250, 2005
14. Gopalan G, Chan CS, Donovan PJ: A novel mammalian, mitotic spindle-associated kinase is related to yeast and fly chromosome segregation regulators. J Cell Biol 138:643-656, 1997
15. Kitzen JJ, de Jonge MJ, Verweij J: Aurora kinase inhibitors. Crit Rev Oncol Hematol 73:99-110, 2010
16. Klein A, Reichardt W, Jung V, Zang KD, Meese E, Urbschat S: Overexpression and amplification of STK15 in human gliomas. Int J Oncol 25:1789-1794, 2004
17. Kuratsu J, Estes JE, Yokota S, Mahaley MS Jr, Gillespie GY: Growth factors derived from a human malignant glioma cell line, U-251MG. J Neurooncol 7:225-235, 1989 (Pubitemid 19225512)
18. Milam MR, Gu J, Yang H, Celestino J, Wu W, Horwitz IB, et al: STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study. Gynecol Oncol 107:71-74, 2007
19. Neben K, Korshunov A, Benner A, Wrobel G, Hahn M, Kokocinski F, et al: Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 64:3103-3111, 2004
20. Ogawa E, Takenaka K, Katakura H, Adachi M, Otake Y, Toda Y, et al: Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC). Ann Surg Oncol 15: 547-554, 2008
21. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173, 2006
22. Reichardt W, Jung V, Brunner C, Klein A, Wemmert S, Romeike BF, et al: The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncol Rep 10:1275-1279, 2003
23. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM: Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 275:9390-9395, 2000 (Pubitemid 30185164)
24. Samaras V, Stamatelli A, Samaras E, Arnaoutoglou C, Arnaoutoglou M, Stergiou I, et al: Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features. Pathol Res Pract 205:765-773, 2009
25. Sathornsumetee S, Rich JN: Designer therapies for glioblastoma multiforme. Ann N Y Acad Sci 1142:108-132, 2008
26. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, et al: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40:51-55, 1998
27. Scott JN, Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, et al: Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci 25: 197-201, 1998 (Pubitemid 28368794)
28. Wang R, Wang JH, Chu XY, Geng HC, Chen LB: Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance. Clin Biochem 42:641-647, 2009
29. Yang SB, Zhou XB, Zhu HX, Quan LP, Bai JF, He J, et al: Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma. Oncol Rep 17:1083-1088, 2007